| 1 |
LU2346866317 |
Candriam Equities L Oncology, N - Capitalisation |
+39,53 % |
+16,40 % |
2,25 |
| 2 |
LU2387456671 |
Franklin Genomic Advancements Fund - I (acc) EUR |
+51,11 % |
+21,96 % |
2,21 |
| 3 |
IE000G3N3NE7 |
Janus Henderson Global Life Sciences Fund G2 EUR |
+36,70 % |
+15,52 % |
2,20 |
| 4 |
IE00BRJG6X20 |
Janus Henderson Global Life Sciences Fund I2 EUR |
+35,57 % |
+15,48 % |
2,13 |
| 5 |
LU2488093530 |
Tareno Impact Healthcare Fund - Klasse B CHF (Acc) |
+34,85 % |
+15,19 % |
2,12 |
|
|
| 136 |
LU2243635674 |
Goldman Sachs Global Future Health Care Equity Portfolio Class I Shares (Acc.) (EUR) |
+19,70 % |
+15,49 % |
1,10 |
|
|
| 338 |
LU0580275534 |
Bellevue Funds (Lux) - Bellevue Medtech & Services HB EUR - Accumulating |
-12,95 % |
+16,48 % |
-0,94 |
| 339 |
LU0969575645 |
Variopartner SICAV - MIV Global Medtech Fund I3 USD |
-14,45 % |
+17,30 % |
-0,99 |
| 340 |
LU1050446076 |
Variopartner SICAV - MIV Global Medtech Fund N3 USD |
-14,62 % |
+17,30 % |
-1,00 |
| 341 |
LU0969575561 |
Variopartner SICAV - MIV Global Medtech Fund P3 USD |
-14,96 % |
+17,31 % |
-1,02 |
| 342 |
LU0580237955 |
Bellevue Funds (Lux) - Bellevue Medtech & Services HB CHF - Accumulating |
-14,47 % |
+16,47 % |
-1,04 |